论文部分内容阅读
目的研究系统骨质疏松治疗在降低老年骨折患者二次骨折发生率与死亡率中的作用。方法 128例骨质疏松骨折患者随机分为观察组和对照组,每组64例。对照组为常规治疗,观察组为系统骨质疏松治疗,随访时间为1年,比较两组患者的骨质密度、术后再次骨折发生时间、二次骨折发生率与死亡率。结果 1观察组的术后再次骨折发生时间明显长于对照组,两组数据对比差异有统计学意义(P<0.05)。观察组治疗后的骨密度(BMD)T值(BMD-T值)发生明显改变,与对照组比较差异有统计学意义(P<0.05)。2观察组的再次骨折率(4.7%VS 17.2%)、死亡率(1.6%VS 10.9%)均低于对照组,数据对比差异有统计学意义(P<0.05)。结论系统骨质疏松治疗能够使老年骨折患者二次骨折发生率与死亡率得以降低,取得较好的效果,值得临床推广应用。
Objective To study the role of systemic osteoporosis in reducing the incidence of secondary fracture and mortality in elderly patients with fractures. Methods 128 cases of osteoporosis fracture were randomly divided into observation group and control group, 64 cases in each group. The control group was treated routinely. The observation group was treated by systemic osteoporosis. The follow-up time was 1 year. The bone density, time of secondary fracture, secondary fracture and mortality were compared between the two groups. Results 1 The postoperative fracture time of the observation group was significantly longer than that of the control group, the difference between the two groups was statistically significant (P <0.05). The bone mineral density (BMD) T value (BMD-T) of the observation group changed significantly after treatment, which was significantly different from the control group (P <0.05). The rate of secondary fracture (4.7% VS 17.2%) and mortality (1.6% VS 10.9%) in the observation group were lower than those in the control group. The difference was statistically significant (P <0.05). Conclusion Systemic osteoporosis treatment can reduce the incidence of secondary fracture and mortality in elderly patients with fractures, and achieve good results, which is worthy of clinical application.